Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload

Documenti analoghi

• Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major
  di: Karami, Hossein, et al.
  Pubblicazione: (2017)
• Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions
  di: Neufeld, Ellis J.
  Pubblicazione: (2006)
• Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major
  di: Musallam, Khaled M., et al.
  Pubblicazione: (2011)
• Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia
  di: Al-Khabori, Murtadha, et al.
  Pubblicazione: (2013)
• Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone)
  di: Wali, Yasser, et al.
  Pubblicazione: (2008)